Avanos Medical (AVNS) EPS (Weighted Average and Diluted) (2016 - 2024)
Historic EPS (Weighted Average and Diluted) for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to $0.12.
- Avanos Medical's EPS (Weighted Average and Diluted) rose 16315.79% to $0.12 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.42, marking a year-over-year increase of 12876.71%. This contributed to the annual value of -$1.32 for FY2023, which is 22336.45% down from last year.
- Latest data reveals that Avanos Medical reported EPS (Weighted Average and Diluted) of $0.12 as of Q3 2024, which was up 16315.79% from $0.09 recorded in Q2 2024.
- In the past 5 years, Avanos Medical's EPS (Weighted Average and Diluted) registered a high of $0.79 during Q2 2021, and its lowest value of -$1.46 during Q2 2023.
- Over the past 5 years, Avanos Medical's median EPS (Weighted Average and Diluted) value was $0.08 (recorded in 2020), while the average stood at -$0.08.
- As far as peak fluctuations go, Avanos Medical's EPS (Weighted Average and Diluted) tumbled by 75833.33% in 2020, and later surged by 141666.67% in 2021.
- Avanos Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.03 in 2020, then soared by 48.54% to -$0.53 in 2021, then soared by 167.92% to $0.36 in 2022, then tumbled by 36.11% to $0.23 in 2023, then tumbled by 47.83% to $0.12 in 2024.
- Its EPS (Weighted Average and Diluted) stands at $0.12 for Q3 2024, versus $0.09 for Q2 2024 and -$0.02 for Q1 2024.